Cargando…

Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model

Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and adherence to physical activity in patients with non-alcoholic fatty liver disease (NAFLD), as well as the association between social support and adherence to diet. We also examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Funuyet-Salas, Jesús, Martín-Rodríguez, Agustín, Pérez-San-Gregorio, María Ángeles, Romero-Gómez, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161151/ https://www.ncbi.nlm.nih.gov/pubmed/34065216 http://dx.doi.org/10.3390/jcm10102208

Ejemplares similares

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Quality of Life and Coping in Nonalcoholic Fatty Liver Disease: Influence of Diabetes and Obesity
por: Funuyet-Salas, Jesús, et al.
Publicado: (2021)

Significance of Post-Traumatic Growth and Mental Health for Coping in Multiple Sclerosis Caregivers
por: Gil-González, Irene, et al.
Publicado: (2023)

Relationship Between Self-Perceived Health, Vitality, and Posttraumatic Growth in Liver Transplant Recipients
por: Funuyet-Salas, Jesús, et al.
Publicado: (2019)

Self-reported psychological development in cosmetic breast surgery patients
por: Pérez-San-Gregorio, María Ángeles, et al.
Publicado: (2016)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
por: Gallego-Durán, Rocío, et al.
Publicado: (2016)

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
por: Lemmer, Peter, et al.
Publicado: (2022)

The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
por: Oh, Hyunwoo, et al.
Publicado: (2023)

Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
por: Francisco, Vera, et al.
Publicado: (2022)

Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
por: Petroni, Maria L., et al.
Publicado: (2019)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
por: Choi, Jong Hwa, et al.
Publicado: (2020)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Psychological precursors of individual differences in COVID-19 lockdown adherence: Moderated-moderation by personality and moral cognition measures
por: Lo Presti, Sara, et al.
Publicado: (2021)

Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
por: Kwon, Inbeom, et al.
Publicado: (2019)

Biomarkers of moderate alcohol intake and alcoholic beverages: a systematic literature review
por: Trius-Soler, Marta, et al.
Publicado: (2023)

Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention
por: Romero-Gómez, Manuel, et al.
Publicado: (2023)

Correction: Biomarkers of moderate alcohol intake and alcoholic beverages: a systematic literature review
por: Trius-Soler, Marta, et al.
Publicado: (2023)

Concerns, Mental Health, and Quality of Life in Living Kidney Donation–Parent Donor Candidates Worry Less about Themselves
por: Pérez-San-Gregorio, M. Ángeles, et al.
Publicado: (2017)

Quality of life in adults with multiple sclerosis: a systematic review
por: Gil-González, Irene, et al.
Publicado: (2020)

Beyond the Boundaries of Disease—Significant Post-traumatic Growth in Multiple Sclerosis Patients and Caregivers
por: Gil-González, Irene, et al.
Publicado: (2022)

Coping Strategies Furthering Post-Traumatic Growth in Multiple Sclerosis: A Longitudinal Study
por: Gil-González, Irene, et al.
Publicado: (2022)

Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
por: Rojas, Ángela, et al.
Publicado: (2022)

The immune response as a therapeutic target in non-alcoholic fatty liver disease
por: Ortiz-López, Nicolás, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients
por: Belinchón-Romero, Isabel, et al.
Publicado: (2021)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Emerging Diagnostics and Therapeutics for Non-alcoholic Fatty Liver Disease
por: Darbhanga, Jake, et al.
Publicado: (2023)

Purging behaviors and therapeutic prognosis of women with eating disorders treated in a healthcare context
por: Avargues-Navarro, María Luisa, et al.
Publicado: (2017)

Coping Strategies in Liver Transplant Recipients and Caregivers According to Patient Posttraumatic Growth
por: Pérez-San-Gregorio, M. Ángeles, et al.
Publicado: (2017)

Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease
por: Monserrat-Mesquida, Margalida, et al.
Publicado: (2023)

Effects of Moderate Alcohol Intake in the Bladder of the Otsuka Long Evans Tokushima Fatty Diabetic Rats
por: Bae, Woong Jin, et al.
Publicado: (2015)

Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis
por: Maurelli, Martina, et al.
Publicado: (2023)

Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men
por: Liu, Peiyi, et al.
Publicado: (2017)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Gallego-Durán, Rocío, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications
por: Klujszo, Elzbieta H., et al.
Publicado: (2019)

The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease
por: Filipovic, Branka, et al.
Publicado: (2021)

Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
por: Teng, Tieshan, et al.
Publicado: (2022)

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
por: Bhattacharyya, Anamika, et al.
Publicado: (2017)

Post-traumatic growth and its relationship to quality of life up to 9 years after liver transplantation: a cross-sectional study in Spain
por: Pérez-San-Gregorio, María Ángeles, et al.
Publicado: (2017)

Higher Adherence to Healthy Lifestyle Score Is Associated with Lower Odds of Non-Alcoholic Fatty Liver Disease
por: Zhu, Yu, et al.
Publicado: (2022)

Adherence to low carbohydrate diets and non-alcoholic fatty liver disease: a case control study
por: Yaghoubi, Fatemeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iaqun8idnt5f77pr6tlmmmaend